Loading
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (3 ops.)
Latest filing published 08 Apr 2024 for NGM Biopharmaceuticals INC.
Filing timeline
BuySaleWilliam Jl Rieflin
Insider track record
Disclosed buys
7
Disclosed sells
3
Signal history
Closed purchases
Market purchases
7
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
William Jl Rieflin: trading record in brief
William Jl Rieflin discloses dealings in 4 companies, chiefly Xenoport Inc, Anacor Pharmaceuticals, Inc. and RAPT Therapeutics, Inc. We count 46 filings; the first trade dates from 16 November 2005 and the latest from 5 April 2024.
Both buying and selling appear: 7 purchases worth €340k, against 3 sales worth €75k. Netting one side against the other leaves €265k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant and 16 option exercises.
In size, the median ticket on the buying side is €30k.
The newest entry dates from 8 April 2024: a transaction, in NGM Biopharmaceuticals Inc. The last insider purchase was made public on 20 November 2020, 2,163 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to William Jl Rieflin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations45 total
2,769,168 sharesCommon StockSEC:0000950170-24-042619:1
5,172 sharesCommon StockSEC:0000950170-24-042619:0
10,000 shares@ US$16.22100.0% of flowCommon StockSEC:0001593968-20-002227:0
Canonical exit: 17 Feb 2021 (T+90)
43,390 sharesCommon StockSEC:0001209191-19-055033:0
16,666 sharesCommon StockSEC:0001209191-19-055033:1
8,000 shares@ US$12.0038.6% of flowCommon StockSEC:0001209191-19-055033:2
Canonical exit: 2 Feb 2020 (T+90)
56,668 sharesCommon StockSEC:0001209191-19-024198:0
281,117 shares@ US$7.0389.9% of flowCommon StockSEC:0000899243-16-024689:1
68 shares@ US$7.030.0% of flowCommon StockSEC:0000899243-16-024689:2
31,660 shares@ US$7.0310.1% of flowCommon StockSEC:0000899243-16-024689:0
89,000 shares@ US$99.2591.5% of flowCommon StockSEC:0000950103-16-014339:0
853 shares@ US$99.250.9% of flowCommon StockSEC:0000950103-16-014339:1
5,000 shares0Common StockSEC:0001209191-16-121811:0
30,000 shares@ US$6.922.1% of flowCommon StockSEC:0001209191-16-112623:0
7,500 shares@ US$6.740.5% of flowCommon StockSEC:0001209191-16-112623:1
12,500 shares@ US$5.200.7% of flowCommon StockSEC:0001209191-16-112623:2
15,000 shares@ US$5.110.8% of flowCommon StockSEC:0001209191-16-112623:3
24,000 shares@ US$14.223.5% of flowCommon StockSEC:0001209191-16-112623:4
853 shares0Common StockSEC:0001209191-15-052481:0
5,000 shares0Common StockSEC:0001209191-15-045638:0
2,918 shares@ US$8.49Common StockSEC:0001209191-14-075004:0
5,592 shares@ US$8.49Common StockSEC:0001209191-14-075004:1
2,500 shares@ US$8.49Common StockSEC:0001209191-14-075004:2
5,000 shares0Common stockSEC:0001209191-14-034806:0
5,000 shares0Common stockSEC:0001209191-13-027000:0
25 of 45 declarations
